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Abstract
Multifunctional materials with excellent biocompatibility and electron-transport properties are critical for the pursuit of point-of-care biosens-
ing devices. The authors report the synthesis of zinc oxide–reduced graphene oxide (ZnO–rGO) nanocomposite for the fabrication of an elec-
trochemical immunosensing test-bed for noninvasive onsite detection of oral cancer biomarker (interleukin-8, IL8). The immunosensor
showed successful detection of IL8 at low concentration ranges, i.e., 100 fg/mL–5 ng/mL with a sensitivity of 12.46 ± 0.82 µA mL/ng and
a detection limit of 51.53 ± 0.43 pg/mL. These results have been validated through in vitro investigations using real saliva samples spiked
with IL8.
Introduction
The frantic working schedules, worldwide witnessed by human
race, are associated with the increasing incidences of chronic
diseases such as diabetes, stress, cancer, and other metabolic
disorders. Oral squamous cell carcinoma (OSCC) is highly
prevalent globally and is a major cause for high mortality
rate[1] with a higher number in south-east Asian countries.[2]
It is one of the common forms of head and neck cancer that
involves the formation of cancerous lesions around the oral
cavity and oropharynx.[3] Major risk factors include tobacco
usage, alcohol consumption, smoking, and human papillomavi-
rus (HPV) infection, while other less prominent factors are poor
oral hygiene, improper diet, microbial infection, chronic expo-
sure to sun, or certain chemicals.[3] The delay in diagnosis of
the onset of disease remains one of the major contributors to
the low survival rate due to oral cancer. In addition to this,
the classical methods are invasive, labor-intensive, and expen-
sive making the detection process quite cumbersome for rou-
tine diagnosis.[4] This poses a strong need to develop easy to
use, fast, and accurate diagnostic tools. To this end, the
point-of-care devices, such as biosensors, are the preferred
options in healthcare services.
With the identification of various oral cancer-specific bio-
markers (proteins expressed by cancerous cells that are indica-
tive of its progress), the prospect of early-stage detection
and treatment follow-ups may witness a paradigm shift.[5]
Electrochemical detection of tumor-specific biomarkers
through specific biosensing devices promises for point-of-care
and early detection of oral cancer.[6] Interleukin-8 (IL8) is one
such biomarker from the family of cytokines that plays a vital
role in tumor growth and metastatic processes in many cancer
types.[7] IL8 marks the oral cancer progression with its signifi-
cantly high levels of expression in saliva (720 pg/mL) of OSCC
patients compared to that in healthy persons (250 pg/mL).[8]
This wide difference in the expression level of IL8 in saliva
makes it an intriguing tool for developing noninvasive biosen-
sor for salivary OSCC detection. This diagnostic tool may
promise for accurate and reliable oral cancer diagnosis as
well as its monitoring throughout the treatment procedures.
The amalgamation of nanomaterials-based transducer sys-
tems into electrochemical biosensing devices has recently
attracted a lot of attention of the researchers due to their ability
to provide fast, simple, and accurate measurement of biomark-
ers present at very low concentrations in the body fluids.[9,10]
Among various nanomaterials proposed, graphene oxide
(GO), a planar lattice structure comprising of sp2-bonded car-
bon in a honeycomb network along with few sp3-bonded car-
bon attached to functional groups, exhibits outstanding
properties, namely high surface area, mechanical strength, con-
ductivity, and charge carrier mobility, making it a preferred
nanomaterial for biosensing applications.[11] Moreover, new
prototypes involving conjugation of nanoparticles with
enhanced heterogeneous electron-transport properties on GO
sheets (or its derivatives) are being fervently looked upon
to attain advancement in biosensing capability in terms of
specificity and disease monitoring time.[12,13] ZnO nanoparti-
cles are direct bandgap semiconductors known for high
charge transfer capabilities and biocompatible nature with
high surface area to volume ratio that provide a suitable
microenvironment for immobilization, as well as stability of
biomolecules on their surface.[14] It was envisioned that inte-
gration of GO (or its derivatives) with ZnO nanoparticles
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could significantly raise the sensitivity of the electrochemical
biosensors.
Here, we report the synthesis of zinc oxide–reduced gra-
phene oxide (ZnO–rGO) nanocomposite and its application
as transducer matrix for the fabrication of a label-free, noninva-
sive, and cost-effective immunosensing platform for sensitive
detection of oral cancer biomarker (IL8). The immunosensor
showed successful detection of oral cancer biomarker “IL8”
at sub-picomolar ranges with very high sensitivity, selectivity,
and good stability. The enhanced electron-transfer property
exhibited by ZnO–rGO nanocomposite allowed efficient detec-
tion of IL8 in saliva as well. The immunosensor represents an
edge over classical diagnosis methods for faster detection and
clinical evaluation of tumor progression in OSCC patients.
Materials and methods
Reagents and techniques
The chemicals used for the synthesis of GO, i.e., potassium per-
manganate, sulfuric acid, sodium nitrate, hydrogen peroxide,
were obtained from Merck India Pvt. Ltd., while graphite pow-
der was provided by Acros Organics. ZnO nanoparticles were
prepared using zinc acetate dihydrate and lithium hydroxide
as precursors obtained from Sigma-Aldrich India. A 1:1 (v/v)
composition of N-ethyl-N′-(3-dimethylaminopropyl) carbodii-
mide hydrochloride (EDC) and N-hydroxysuccinimide (NHS)
obtained from Sigma-Aldrich India was used for activation of
carboxylic groups in ZnO–rGO composite. Other chemicals
used for preparation of Zobell’s solution (potassium hexacya-
noferrate(II) trihydrate, potassium hexacyanoferrate(III), potas-
sium chloride), phosphate buffer saline (PBS; potassium
phosphate monobasic, sodium phosphate dibasic dihydrate,
sodium chloride), and blocking agent (ethanolamine) were of
ACS grade, also purchased from Sigma-Aldrich. Indium-
coated tin oxide (ITO) substrates were provided by Macwin,
India. The target antigen IL8 and its corresponding antibody,
i.e., polyclonal IL8 antibody derived from rabbit, were pur-
chased from Bioss, USA.
The physicochemical characterizations were performed
using powder x-ray diffractometry (XRD) [model used:
Rigaku miniflex 300 containing Cu Kα x-ray source], UV–
Visible (UV–Vis) spectrophotometry [model used: Agilent
Cary 5000], energy-dispersive x-ray spectroscopy (EDX)
[model used: Zeiss EVOMA10], and transmission electron
microscopy (TEM) [model used: Tecnai G2 F30 STWIN].
Cyclic voltammetry (CV) and differential pulse voltammetry
(DPV) techniques were used to perform electrochemical mea-
surements on PalmSens3 potentiostat in conjugation with a
three-electrode system where silver/silver chloride (Ag/AgCl)
electrode and Pt-mesh wire, respectively, were used as refer-
ence and counter electrodes, while fabricated nanocomposite-
based electrodes were applied as working electrodes.
Synthesis of ZnO–rGO nanocomposite
The ZnO–rGO nanocomposite was synthesized from GO and
ZnO nanoparticles using the wet chemical route. Firstly,
modified Hummer’s method reported by Cote et al.[15] was
applied for the synthesis of highly exfoliated two-dimensional
powdered GO. The powdered GO was uniformly dispersed into
ethanol through sonication to prepare 1 mg/mL GO solution.
Then, ZnO nanoparticles of ∼3-5 nm were synthesized using
the sol–gel process reported elsewhere[16] with 0.13 M zinc
acetate dihydrate (as Zn2+ ion source) and 0.34 M lithium
hydroxide monohydrate (as OH− ions source) solutions
prepared in ethanol. Finally, 3 mL of as-synthesized ethanolic
dispersion of ZnO nanoparticles was mixed with 50 mL of
1 mg/mL ethanolic solution of GO and stirred overnight at
room temperature. The overnight reaction led to the formation
of ZnO nanoparticles on defect sites of rGO that was formed
during the reaction from GO due to reducing properties of lith-
ium hydroxide monohydrate present in the reaction mixture.
The ZnO–rGO nanocomposite solution so obtained was uti-
lized further for bioelectrode preparation.
Fabrication of bioelectrodes and response
measurements
The thin films of ZnO–rGO nanocomposite were deposited
onto ITO-coated glass substrates (6 × 15 mm2) using the spin
coating technique. Then, 50 µL of 1:1 v/v EDC (0.5 M)–NHS
(0.1 M) mixture was dropcasted on the film surface and left
undisturbed for 30 min. The electrodes were washed with
50 mM PBS and then treated with 20 µL of 1 µg/mL of IL8
antibodies followed by incubation for 4 h. After the immobili-
zation of antibodies, the films were again washed with PBS and
then coated with 1 M ethanolamine to block the unbound active
sites on ZnO–rGO surface. The electrochemical activity of the
films before and after surface modification was determined
using the CV technique. The prepared bioelectrodes (Anti-
IL8/ZnO–rGO/ITO) were finally exposed to various concentra-
tions of IL8 antigen for 10 min duration for which the response
studies were assessed using the DPV method. The overall fab-
rication process of Anti-IL8/ZnO–rGO/ITO immunoelectrodes
and the electrochemical setup used for conducting the electro-
chemical studies are demonstrated with the aid of a schematic
shown in Fig. 1.
Results and discussion
Characterization of ZnO–rGO nanocomposite
The structural and morphological features of the synthesized
ZnO–rGO nanocomposite were investigated using various
characterization techniques, i.e., Powder XRD, UV–Vis spec-
troscopy, EDX and TEM. X-ray diffraction pattern [Fig. 2(a)]
of the ZnO–rGO nanocomposite was measured in order to
explore its crystal structure. The XRD peaks in the 2θ range
30°–80° exhibited peaks related to (100), (002), (101), (102),
(110), (103), (112), (202) planes that matched well with
the hexagonal wurtzite structure of ZnO nanoparticles indexed
with JCPDS card no. 36-1451.[17] A broad hump at 2θ ∼23.8°
was also observed that indicated the formation of rGO in the
nanocomposite system.[18]
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Figure 2(b) shows the UV–Vis spectrum of the ZnO–rGO
nanocomposite that comprised of red-shifted absorption peak
related to n–π* (256 nm) transition occurring in rGO along
with the characteristic absorption peak of ZnO nanoparticles
at 347 nm indicating the conjugation of ZnO nanoparticles
with GO.[19] The optical bandgap of ZnO–rGO nanocomposite
was determined from the extrapolation of linear portion to the
intercept of x-axis in a plot between (αhυ)2 versus energy
(eV), i.e., Tauc’s plot.[20] The prepared nanocomposite showed
a smaller bandgap value (i.e., 3.36 eV) in comparison to
Figure 1. Schematic diagram showing (a) the fabrication process of Anti-IL8/ZnO–rGO/ITO immunosensor and (b) the electrochemical setup applied for
recording the electro-analytical measurements of the prepared immunosensor.
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Figure 2. (a) Powder XRD pattern and (b) solution-based UV–Vis spectrum of ZnO–rGO nanocomposite. Inset shows Tauc’s plot associated with the obtained
optical behavior of ZnO–rGO nanocomposite. (c) EDX spectra and bar graph showing the chemical composition of ZnO–rGO nanocomposite film on ITO.
(d) TEM images of GO and ZnO–rGO nanocomposite solutions deposited on 200-mesh copper grids.
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unbound ZnO nanoparticles (bandgap—3.62 eV) (figure not
shown) indicating toward facile charge transfer capability of
the composite.
The elemental composition of the prepared nanocomposite
was identified by subjecting the thin films of ZnO–rGO on
ITO-coated glass (prepared using the spin-coating technique)
to EDX analysis. The EDX spectrum [Fig. 2(c)] revealed
peaks related to C and Zn belonging to the prepared nano-
composite, while the other peaks denoting In, Sn and Si were
coming from the ITO substrate. The high intensity peak for
O element was obtained due to contribution from both the nano-
composite and the ITO substrate. The quantitative distribution of
these elements is depicted through the bar graph in Fig. 2(c).
The morphology of the ZnO–rGO nanocomposite was
viewed at an atomic scale using a panel of TEM images
recorded at different scales [Fig. 2(d)]. The TEM image of
GO showed crumpled sheet-like structure with high transpar-
ency, while the TEM image of ZnO–rGO showed the dense dis-
tribution of monodispersed ZnO nanoparticles (∼3–5 nm in
size) onto the sheets of rGO further confirming the self-
assembly of ZnO onto rGO surface.
Electrochemical studies
The electrochemical activity of the prepared thin films was
evaluated by employing the CV technique for studying the
redox reaction of ferro–ferri couple (i.e., Zobell’s solution) at
varying scan rates (0.02–0.24 V/s) using ZnO–rGO/ITO films
as working electrodes [Fig. 3]. The recorded CV curves showed
an increase in redox current with increasing scan rates in accor-
dance with the Randles–Sevcik equation [Eq. (1)] that defines a
direct relationship between current and square roots of scan rates:
Ip = (2.69× 105)n3/2ACD1/2n1/2 (1)
where Ip is the anodic/cathodic peak current, n is the number of
electrons involved in the redox process, A is the active surface
area of electrode, C is the molar concentration of the redox spe-
cies, D is the diffusion coefficient specific to the redox process,
and ν is the applied scan rate value.
The films revealed quasi-reversible electrochemical charac-
teristics as evident from the shift in potential values, Ep (a pos-
itive shift in oxidation cycle and a negative shift in reduction
cycle), corresponding to anodic (Ipa) and cathodic (Ipc) peak
currents with a successive increase in scan rate. The ratio for
forward-to-reverse peak currents lying in the range 1 < Ipa/Ipc
< 1.29 additionally verified the occurrence of quasi-reversible
electrochemistry at ZnO–rGO/ITO electrode where the rates
of electron transfer and mass transfer are comparable.[21]
Further, the graph given in Fig. 3 (inset) illustrates the straight
line behavior of peak currents (μA) with respect to square
root of scan rates (V1/2/s1/2) having correlation coefficient,
R2 = 0.9998 and 0.9996 (<1), suggesting the diffusion-based
electron-transport process in the vicinity of the electrode.[21,22]
The ZnO–rGO/ITO electrodes were subjected to controlled
immobilization process for covalent attachment of Anti-IL8
antibodies on their surface. The successful immobilization of
the antibodies on ZnO–rGO/ITO electrodes was determined
through FTIR spectroscopic measurements, given in
Supplementary Fig. S1(a), that showed peaks related to stretch-
ing frequencies of amide C=O and N–H bonds, thus confirming
the formation of amide linkage between antibody and the nano-
composite system. The resulting immunoelectrodes, Anti-IL8/
ZnO–rGO/ITO, were tested for their response toward IL8 at a
concentration range of 100 fg/mL–5 ng/mL using the DPV
technique with applied pulse potential 0.02 V and 0.07 s of
pulse time [Fig. 4(a)]. DPV curves, recorded to account for
the antibody–antigen binding event, showed sharp well-defined
oxidation peaks whose current (Ip) values decreased with
increasing analyte concentrations due to the presence of low
conducting protein layer at the electrode interface. The optimal
response time of the immunoelectrode toward IL8 was found to
be 10 min. A calibration curve between peak current and ana-
lyte concentration was constructed [Fig. 4(a) inset], giving a
linear response of current signal with the exposed IL8 concen-
tration with the linear regression equation:
Ip = −0.01246 [IL8 conc.]+ 62.6864, R2 = 0.99303 (2)
The sensitivity of Anti-IL8/ZnO–rGO/ITO immunosensor
as derived from the slope of the calibration curve was found
to be 12.46 ± 0.82 µA mL/ng. The value for the limit of
detection (LOD) of the immunosensor was calculated to be
51.53 ± 0.43 pg/mL (n = 3) using the following equation[23,24]:
LOD = k × s
S
(3)
where k = 3 corresponding to the confidence level parameter,
σ is the standard deviation value for response signals obtained
Figure 3. CV curves recorded at ZnO–rGO/ITO electrode for 3 mM Zobell’s
solution with varying scan rates. Inset shows the plot of anodic/cathodic peak
currents versus square root of scan rates.
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in the absence of an analyte, and S is the slope of the calibration
plot which is equal to the sensitivity of the electrode.
Specificity is an important parameter that the immunosensor
must exhibit in order to prevent false positives. To ensure the
specificity of our fabricated immunosensor, it was exposed
to other nontarget biomarker proteins, i.e., hTERT, S-100,
MAGE-A2, and CD59, each having concentration of 700 pg/mL
[Fig. 4(b)]. It was found that the oxidation peak current value
for each of the nonspecific analytes was comparable to the
response signal of the blank sample (i.e., control sample not
containing any analyte) indicating negligible interference of
the nonspecific analytes on the response of the immunosensor
due to their noninteraction with the immobilized antibody on
the electrode surface. On the other hand, the current decreased
significantly when the immunosensor was exposed to the target
analyte, i.e., IL8, confirming high specificity of immunosensor
toward IL8 antigen. The high sensitivity and specificity
exhibited by the immunosensor validates its superior electro-
chemical performance attributable to the structural defects
induced low energy gap in the nanocomposite causing fast
electron mobility.
In order to establish the diagnostic capability of the fabri-
cated immunosensor, its performance was investigated in real
biological samples. Four different concentrations (400 pg/mL,
700 pg/mL, 1 ng/mL, and 2 ng/mL) of standard IL8 were
spiked into the saliva samples (in its undiluted form) collected
from healthy volunteers and exposed to the immunosensor for
10 min duration. The response of the immunosensor recorded
Figure 4. (a) DPV curves showing the response of Anti-IL8/ZnO–rGO/ITO immunoelectrode toward different concentrations of standard IL8 antigen (prepared in
50 mM PBS) in 3 mM Zobell’s solution. Inset shows the corresponding calibration curve between the response current and concentration. (b) Bar graph
showing the immunosensor response toward nontarget analytes in comparison with response toward IL8. (c) DPV curves showing the performance of
immunosensor toward spiked IL8 concentrations in saliva. Inset shows the calibration plot of current versus concentration obtained for spiked saliva samples.
(d) Bar graph illustrating the activity of the immunosensor after seven regeneration cycles.
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using a DPV technique [Fig. 4(c)] revealed unhindered detec-
tion of the spiked IL8 concentrations with a calibration curve
fitting in the given linear regression equation:
Ip = −0.01157 [IL8 conc.]+ 60.14812, R2 = 0.99539 (4)
The sensitivity (11.57 ± 0.72 µA mL/ng) obtained from the
calibration curve [Fig. 4(c) inset] in case of saliva samples
was quite comparable to that obtained for standard IL8 sam-
ples, thus proving the negligible matrix effect on the function-
ing of the immunoelectrodes. Further, the immunosensor
exhibited appreciable recovery values in the range 95%–
100%, for all the spiked IL8 concentrations with relative stan-
dard deviation (RSD) < 4%, signifying its competency for diag-
nosis of biological samples.
The regeneration capability of the immunosensor was also
determined by subjecting the immunoelectrodes to 30 mM
NaOH solution (pH 12) for 90 s to allow breaking of anti-
gen–antibody interaction and then recording the oxidation
cycle (n = 3) using the DPV. As evident from the bar graph
[Fig. 4(d)] showing the current obtained after each regeneration
cycle, the immunosensor retained 98.8% activity after the first
regeneration cycle. The activity of the immunosensor then
decreased to 95.7% after the third cycle and further down to
92.6% in the fifth cycle. After five regeneration cycles, the bio-
chemical activity reduced significantly, implying that the
immunosensor could effectively work for five successive uses.
The stability of the immunosensor was also analyzed by
recording its response in triplicate toward 700 pg/mL of IL8
after every 10 days. The obtained results testified reliable per-
formance of the immunosensor for up to 70 days when stored
at 4 °C temperature. Repeatability of results is crucially impor-
tant for the development of a biosensor that could be applied for
reliable clinical diagnosis. To evaluate the repeatability of our
fabricated immunosensor Anti-IL8/ZnO–rGO/ITO, we have
presented the DPV results of 15 sets of measurements for
four different concentrations of IL8 (400 pg/mL, 700 pg/mL,
1 ng/mL, and 2 ng/mL) in Supplementary Fig. S3. The overall
RSD below 3.2% for all the concentrations of IL8 advocated
the high rates of repeatability in the results. However, the little
uncertainty recorded in the current values (given in
Supplementary Table S1) for each of the exposed IL8 concen-
trations possibly arises from the non-ambient experimental con-
ditions, open-ended materials processing practices and
handling errors during antibody fabrication steps.
Conclusion and future outlook
We have highlighted the successful preparation of a robust
immunosensing platform, Anti-IL8/ZnO–rGO/ITO, and its
efficiency to detect oral cancer-specific biomarker IL8 in saliva
samples. The atomically thin rGO sheets provided a high sur-
face area and an ample amount of carboxylic groups that
enabled the covalent attachment of antibodies on its surface.
The overall smaller band structure and electronic synergy of
rGO and ZnO in the nanocomposite matrix led to the
achievement of high sensitivity (12.46 ± 0.82 µA mL/ng) and
a LOD value (51.53 ± 0.43 pg/mL) which is 15 times lower
than the physiochemical level of IL8 in saliva of oral cancer
patients. Additionally, the fabricated immunosensor showed a
remarkable response toward IL8 in saliva samples. The results
obtained from the designed biosensor are reproducible and
serve as a prototype for designing of noninvasive biosensing
platform for diagnosis of other cancerous biomarkers through
a single- or multianalyte-based detection mode.
Supplementary material
The supplementary material for this article can be found at
https://doi.org/10.1557/mrc.2019.138.
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